1.Erratum: Butter Tolerance in Children Allergic to Cow's Milk.
Noriyuki YANAGIDA ; Takanori MINOURA ; Setsuko KITAOKA
Allergy, Asthma & Immunology Research 2016;8(2):178-178
Corrections for Fig. 2 in page 188 are needed.
2.The Hidden Culprit: A Case of Repeated Anaphylaxis to Cremophor.
Young Nam KIM ; Jun Young KIM ; Ji Won KIM ; Jin Hae KIM ; Hye In KIM ; Sehyo YUNE ; Dong Chull CHOI ; Byung Jae LEE
Allergy, Asthma & Immunology Research 2016;8(2):174-177
Drug-induced anaphylaxis is a big pitfall in patients receiving antineoplastic chemotherapy. We report a case of lung cancer patient who experienced two near-fatal anaphylactic reactions that resulted from paclitaxel and multivitamin, seperately. Recurrent severe reactions to different agents led to further investigation to which material the patient was hypersensitive. The skin prick test revealed sensitization to cremophor, which is a commonly used emulsifying agent. This case emphasizes the importance of correctly identifying the culprit drug of anaphylaxis to avoid potentially fatal reaction.
Anaphylaxis*
;
Drug Therapy
;
Humans
;
Hypersensitivity
;
Lung Neoplasms
;
Paclitaxel
;
Skin
3.Papain Induced Occupational Asthma with Kiwi and Fig Allergy.
Nannan JIANG ; Jia YIN ; Liping WEN
Allergy, Asthma & Immunology Research 2016;8(2):170-173
Papain is a proteolytic enzyme which is widely used in food industry, pharmaceuticals, and cosmetics. Occupational and non-occupational papain allergies have previously been documented; however, there are limited publications about papain allergy with its relative fruit allergy. Here, we present a case of occupational, IgE-mediated papain allergy with kiwi fruit and fig fruit allergy. A 53-year-old man suffered from rhinitis for several years, with the onset of his symptoms coinciding with the time he started to work at a sausage processing plant where papain is often used as a meat tenderizer. He began to experience symptoms of chest tightness, shortness of breath and wheezing shortly after starting work 5 years ago. Furthermore, he experienced several episodes of oral itching, and tongue and oropharyngeal angioedema after injestion of kiwi fruit and fig fruit. The patient had a lifelong history of allergic conjunctivitis, allergic rhinitis, and childhood asthma. Specific IgE was positive to kiwi fruit, papain and chymopapain (2.95 kUA/L, >100 kUA/L, and 95.0 kUA/L, respectively). Similar bands at 10-15 kDa in blotting with papain and kiwi fruit extracts were found. This patient showed a potential association between papain allergy and sensitization to kiwi fruit. We also reviewed 13 patients with papain allergy published in the literature, with 85% (11/13) of the patients sensitized through the respiratory tract, and 40% (4/11) having atopy. Further studies should focus on the determination of cross-reactive allergens between papain and its fruit relatives, and the prevalence of food allergy in patients with papain allergy should be investigated in a relatively large cohort.
Allergens
;
Angioedema
;
Asthma
;
Asthma, Occupational*
;
Chymopapain
;
Cohort Studies
;
Conjunctivitis, Allergic
;
Dyspnea
;
Food Hypersensitivity
;
Food Industry
;
Fruit
;
Humans
;
Hypersensitivity*
;
Immunoglobulin E
;
Meat
;
Middle Aged
;
Papain*
;
Plants
;
Prevalence
;
Pruritus
;
Respiratory Sounds
;
Respiratory System
;
Rhinitis
;
Thorax
;
Tongue
4.Administration of Pigment Epithelium-Derived Factor Inhibits Airway Inflammation and Remodeling in Chronic OVA-Induced Mice via VEGF Suppression.
Wangjian ZHA ; Mei SU ; Mao HUANG ; Jiankang CAI ; Qiang DU
Allergy, Asthma & Immunology Research 2016;8(2):161-169
PURPOSE: Pigment epithelium-derived factor (PEDF) is a recently discovered antiangiogenesis protein. PEDF possesses powerful anti-inflammatory, antioxidative, antiangiogenic, and antifibrosis properties. It has been reported that PEDF can regulate vascular endothelial growth factor (VEGF) expression. This study aimed to evaluate whether recombinant PEDF protein could attenuate allergic airway inflammation and airway remodeling via the negative regulation of VEGF using a murine model of chronic ovalbumin (OVA)-induced asthma and BEAS-2B human bronchial epithelial cells. METHODS: In an in vivo experiment, mice sensitized with OVA were chronically airway challenged with aerosolized 1% OVA solution for 8 weeks. Treated mice were given injections of recombinant PEDF protein (50 or 100 microg/kg body weight) via the tail vein. In an in vitro experiment, we investigated the effects of recombinant PEDF protein on VEGF release levels in BEAS-2B cells stimulated with IL-1beta. RESULTS: Recombinant PEDF protein significantly inhibited eosinophilic airway inflammation, airway hyperresponsiveness, and airway remodeling, including goblet cell hyperplasia, subepithelial collagen deposition, and airway smooth muscle hypertrophy. In addition, recombinant PEDF protein suppressed the enhanced expression of VEGF protein in lung tissue and bronchoalveolar lavage fluid (BALF) in OVA-challenged chronically allergic mice. In the in vitro experiment, VEGF expression was increased after IL-1beta stimulation. Pretreatment with 50 and 100 ng/mL of recombinant PEDF protein significantly attenuated the increase in VEGF release levels in a concentration-dependent manner in BEAS-2B cells stimulated by IL-1beta. CONCLUSIONS: These results suggest that recombinant PEDF protein may abolish the development of characteristic features of chronic allergic asthma via VEGF suppression, providing a potential treatment option for chronic airway inflammation diseases such as asthma.
Airway Remodeling
;
Animals
;
Asthma
;
Bronchoalveolar Lavage Fluid
;
Collagen
;
Eosinophils
;
Epithelial Cells
;
Goblet Cells
;
Humans
;
Hyperplasia
;
Hypertrophy
;
Inflammation*
;
Lung
;
Mice*
;
Muscle, Smooth
;
Ovalbumin
;
Ovum
;
Tail
;
Vascular Endothelial Growth Factor A*
;
Veins
5.Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Allergy.
Hye Young KIM ; Youngshin HAN ; Kwanghoon KIM ; Ji Young LEE ; Min Ji KIM ; Kangmo AHN ; Jihyun KIM
Allergy, Asthma & Immunology Research 2016;8(2):156-160
PURPOSE: The purpose of this study was to establish the diagnostic decision point (DDP) of peanut specific IgE (sIgE) for predicting the outcome of oral food challenge (OFC). We also evaluated the usefulness of sIgE to peanut components (Ara h 1, 2, 3, 8, and 9) in diagnosing peanut allergy. METHODS: Korean children aged over 12 months with a suspected peanut allergy were enrolled. Diagnosis of peanut allergy was confirmed by an open OFC or through the convincing history of anaphylaxis. Cutoff levels of sIgE to peanut and peanut components were determined by analyzing receiver operating characteristic curves. RESULTS: Forty-eight children (22 boys and 26 girls) with a suspected peanut allergy were enrolled. The previously established DDP for peanut-sIgE antibodies (14 kU/L) showed a sensitivity of 22.7%, specificity of 100%, positive predictive value (PPV) of 100%, and negative predictive value of 60.4% in our study population. The median levels of peanut-sIgE (5.4 kU/L vs 1.1 kU/L, P<0.001) and Ara h 2-sIgE (0.8 kU/L vs 0 kU/L, P<0.001) were significantly higher in the peanut allergy group than in the peanut tolerance group. The peanut-sIgE concentration indicating a PPV of 100% was 10.3 kU/L. The Ara h 2-sIgE level of 4.0 kU/L had a PPV of 100%. CONCLUSIONS: Our results showed that the cutoff levels for peanut (10.3 kU/L) and Ara h 2 (4.0 kU/L) established in this study is useful for the diagnosis of peanut allergy in Korean children.
Anaphylaxis
;
Antibodies
;
Child*
;
Diagnosis
;
Food Hypersensitivity
;
Humans
;
Immunoglobulin E*
;
Peanut Hypersensitivity*
;
ROC Curve
;
Sensitivity and Specificity
6.Defining Chronic Cough: A Systematic Review of the Epidemiological Literature.
Woo Jung SONG ; Yoon Seok CHANG ; Shoaib FARUQI ; Min Koo KANG ; Ju Young KIM ; Min Gyu KANG ; Sujeong KIM ; Eun Jung JO ; Seung Eun LEE ; Min Hye KIM ; Jana PLEVKOVA ; Heung Woo PARK ; Sang Heon CHO ; Alyn H MORICE
Allergy, Asthma & Immunology Research 2016;8(2):146-155
PURPOSE: Recent evidence suggests a global burden of chronic cough in general populations. However, the definitions vary greatly among epidemiological studies, and none have been validated for clinical relevance. We aimed to examine previous epidemiological definitions in detail and explore the operational characteristics. METHODS: A systematic review was conducted for epidemiological surveys that reported the prevalence of chronic cough in general adult populations during the years 1980 to 2013. A literature search was performed on Pubmed and Embase without language restriction. Epidemiological definitions for chronic cough were classified according to their components, such as cutoff duration. Meta-analyses were performed for the male-to-female ratio of chronic cough prevalence to explore operational characteristics of epidemiological definitions. RESULTS: A total of 70 studies were included in the systematic review. The most common epidemiological definition was identified as 'cough > or =3 months' duration without specification of phlegm (n=50); however, it conflicted with the cutoff duration in current clinical guidelines (cough > or =8 weeks). Meta-analyses were performed for the male-to-female ratio of chronic cough among 28 studies that reported sex-specific prevalence using the most common definition. The pooled male-to-female odds ratio was 1.26 (95% confidence interval 0.92-1.73) with significant heterogeneity (I2=96%, P<0.001), which was in contrast to clinical observations of female predominance from specialist clinics. Subgroup analyses did not reverse the ratio or reduce the heterogeneity. CONCLUSIONS: This study identified major issues in defining chronic cough in future epidemiological studies. The conflict between epidemiological and clinical diagnostic criteria needs to be resolved. The unexpected difference in the gender predominance between the community and clinics warrants further studies. Clinical validation of the existing definition is required.
Adult
;
Cough*
;
Epidemiologic Studies
;
Epidemiology
;
Female
;
Humans
;
Odds Ratio
;
Population Characteristics
;
Prevalence
;
Specialization
7.The Potential for Poverty to Lower the Self-Efficacy of Adults With Asthma: An Australian Longitudinal Study.
Emily J CALLANDER ; Deborah J SCHOFIELD
Allergy, Asthma & Immunology Research 2016;8(2):141-145
PURPOSE: It is known that strong feelings of self-efficacy are linked with better management of asthma. However, it is not known whether the experience of poverty can detrimentally impact the self-efficacy feelings of asthma patients. This paper aims to determine whether falling into income or multidimensional poverty lowers self-efficacy among people diagnosed with asthma. METHODS: Longitudinal analysis of Waves 7 to 11 (2007 to 2011) of the nationally representative Household, Income and Labour Dynamics in Australia (HILDA) survey using generalized linear models. The analysis was limited to those who had been diagnosed with asthma. The Freedom Poverty Measure was used to identify those in multidimensional poverty. RESULTS: People with asthma who fell into income poverty had significantly lower self-efficacy scores-23% lower (95% CI: -35.1 to -9.1), after falling into income poverty for 3 or 4 years between 2007 and 2011 compared to those who were never in income poverty. Those who fell into multidimensional poverty also had significantly lower self-efficacy scores-25% lower (95% CI: -42.8 to -2.0), after being in multidimensional poverty for 3 or 4 years between 2007 and 2011 compared to those who were never in poverty. CONCLUSIONS: Asthmatics who fall into poverty are likely to experience a decline in their feelings of self-efficacy. The findings of this study show that experiencing poverty should be a flag to identify those who may need extra assistance in managing their condition.
Adult*
;
Asthma*
;
Australia
;
Family Characteristics
;
Freedom
;
Humans
;
Linear Models
;
Longitudinal Studies*
;
Poverty*
;
Self Efficacy
8.Increased Expression of miR-146a in Children With Allergic Rhinitis After Allergen-Specific Immunotherapy.
Xi LUO ; Haiyu HONG ; Jun TANG ; Xingmei WU ; Zhibin LIN ; Renqiang MA ; Yunping FAN ; Geng XU ; Dabo LIU ; Huabin LI
Allergy, Asthma & Immunology Research 2016;8(2):132-140
PURPOSE: MicroRNAs (miRs) were recently recognized to be important for immune cell differentiation and immune regulation. However, whether miRs were involved in allergen-specific immunotherapy (SIT) remains largely unknown. This study sought to examine changes in miR-146a and T regulatory cells in children with persistent allergic rhinitis (AR) after 3 months of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). METHODS: Twenty-four HDM-sensitized children with persistent AR were enrolled and treated with SCIT (n=13) or SLIT (n=11) for 3 months. Relative miR-146a and Foxp3 mRNA expression, the TRAF6 protein level, and the ratio of post-treatment to baseline IL-10+CD4+ T cells between the SCIT and SLIT groups were examined in the peripheral blood mononuclear cells (PBMCs) of AR patients using quantitative reverse transcription polymerase chain reaction (qRT-PCR), flow cytometry, and Western blot analysis, respectively. Serum levels of IL-5 and IL-10 were determined using ELISA. RESULTS: After 3 months of SIT, both the TNSS and INSS scores were significantly decreased compared to the baseline value (P<0.01). The relative expression of miR-146a and Foxp3 mRNA was significantly increased after both SCIT and SLIT (P<0.01). The ratio of post-treatment to baseline IL-10+CD4+ T cells and the serum IL-10 level were significantly increased in both the SCIT and SLIT groups (P<0.01), whereas the TRAF6 protein level and serum IL-5 level were significantly decreased (P<0.01). No significant differences in these biomarkers were observed between the SCIT and SLIT groups. CONCLUSIONS: Our findings suggest that miR-146a and its related biomarkers may be comparably modulated after both SCIT and SLIT, highlighting miR-146a as a potential therapeutic target for the improved management of AR.
Biomarkers
;
Blotting, Western
;
Cell Differentiation
;
Child*
;
Enzyme-Linked Immunosorbent Assay
;
Flow Cytometry
;
Humans
;
Immunotherapy*
;
Interleukin-10
;
Interleukin-5
;
MicroRNAs
;
Polymerase Chain Reaction
;
Reverse Transcription
;
Rhinitis*
;
RNA, Messenger
;
Sublingual Immunotherapy
;
T-Lymphocytes
;
TNF Receptor-Associated Factor 6
9.Mimotopes for Api g 5, a Relevant Cross-reactive Allergen, in the Celery-Mugwort-Birch-Spice Syndrome.
Anna LUKSCHAL ; Julia WALLMANN ; Merima BUBLIN ; Gerlinde HOFSTETTER ; Nadine MOTHES-LUKSCH ; Heimo BREITENEDER ; Isabella PALI-SCHOLL ; Erika JENSEN-JAROLIM
Allergy, Asthma & Immunology Research 2016;8(2):124-131
PURPOSE: In the celery-mugwort-birch-spice syndrome, a significant proportion of IgE is directed against high molecular weight (HMW) glycoproteins, including the celery allergen Api g 5. BIP3, a monoclonal antibody originally raised against birch pollen, recognizes HMW allergens in birch and mugwort pollens, celery, and Apiaceae spices. Our aim was to generate mimotopes using BIP3 for immunization against the HMW allergens relevant in the celery-mugwort-birch-spice cross reactivity syndrome. METHODS: Mimotopes were selected from a random-peptide display library by BIP3 and applied in IgE inhibition assays. The 3 phage clones with the highest inhibitory capacity were chosen for immunization of BALB/c mice. Mouse immune sera were tested for IgG binding to blotted birch pollen extract and used for inhibiting patients' IgE binding. Furthermore, sera were tested for binding to Api g 5, to horseradish peroxidase (HRP) as a second glycoprotein, or to non-glycosylated control allergen Phl p 5 in ELISA, and the specific Api g 5-specific IgG titers were determined. RESULTS: Three rounds of biopanning resulted in phage clones exhibiting 7 different sequences including 1 dominant, 1-6-cyclo-CHKLRCDKAIA. Three phage clones had the capacity to inhibit human IgE binding and induced IgG to the HMW antigen when used for immunizing BALB/c mice. The induced BIP3-mimotope IgG reached titers of 1:500 specifically to Api g 5, but hardly reacted to glycoprotein HRP, revealing a minor role of carbohydrates in their epitope. CONCLUSIONS: The mimotopes characterized in this study mimic the epitope of BIP3 relevant for Api g 5, one of the cross-reactive HMW allergens relevant in the celery-mugwort-birch-spice syndrome. BIP3 mimotopes may be used in the future for hyposensitization in this clinical syndrome by virtue of good and specific immunogenicity.
Allergens
;
Animals
;
Apiaceae
;
Apium graveolens
;
Artemisia
;
Bacteriophages
;
Betula
;
Carbohydrates
;
Clone Cells
;
Enzyme-Linked Immunosorbent Assay
;
Food Hypersensitivity
;
Glycoproteins
;
Horseradish Peroxidase
;
Humans
;
Immune Sera
;
Immunization
;
Immunoglobulin E
;
Immunoglobulin G
;
Mice
;
Molecular Weight
;
Pollen
;
Spices
;
Vaccination
;
Virtues
10.Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study.
Young Min YE ; Jung Won PARK ; Sang Ha KIM ; Ga Young BAN ; Ji Hye KIM ; Yoo Seob SHIN ; Hyun Young LEE ; Hae Sim PARK
Allergy, Asthma & Immunology Research 2016;8(2):115-123
PURPOSE: Chronic urticaria (CU) has a substantial impact on the quality of life. Little clinical data on the prognosis of CU has been reported. This study aimed to investigate the control status and remission rate of CU and to explore potential predictors of good responses to the treatment during a 6-month treatment period. METHODS: A total of 75 patients with chronic spontaneous urticaria (CSU) were enrolled from 3 university hospitals in Korea. Urticaria control state was classified into 2 groups: group I (remission and well-controlled) and group II (partly and uncontrolled). CU-specific quality of life (CU-QoL) and the urticaria activity score (UAS) were measured before and after the treatment. Autologous serum skin test (ASST), and anti-nuclear and anti-thyroid antibodies were measured at the enrollment into the study. Aspirin intolerance was confirmed by an oral provocation test. RESULTS: Of 59 patients completing the study, 21 (35.6%) arrived at well-controlled status and only 2 (3.4%) achieved remission, whereas 26 (44.1%) remained at partly controlled status and 10 (16.9%) were at uncontrolled status. Mean changes in CU-QoL (36.5+/-2.7 vs 20.6+/-4.3, P=0.017) and UAS (-7.9+/-0.8 vs -3.0+/-1.0, P=0.001) were significantly different between groups I and II. The presence of serum autoantibodies and aspirin intolerance had no influence on the control of urticaria in this study. However, ASST positivity was identified as a significant predictor of CU control in multivariate analysis (OR=6.106, P=0.017). CONCLUSIONS: The proportion of CSU patients that achieved remission or a well-controlled state was 39% for the 6 months of stepwise treatment. Longer observations are necessary to assess the exact prognosis of CSU. ASST results may be a useful parameter for predicting a better response to treatment and both UAS and CU-QoL are helpful to monitor therapeutic response.
Antibodies
;
Aspirin
;
Autoantibodies
;
Hospitals, University
;
Humans
;
Korea
;
Multivariate Analysis
;
Observational Study*
;
Prognosis
;
Prospective Studies*
;
Quality of Life
;
Skin Tests
;
Urticaria*